Introduction

Erik is a shareholder in Fredrikson & Byron’s Securities, Renewable Energy, Corporate, Mergers & Acquisitions, Clean Technology, and Emerging Business Groups focusing in corporate and renewable energy finance, mergers and acquisitions, power purchase agreements and hedging/swap arrangements, securities, joint ventures, nonprofit trade associations, and a wide variety of issues concerning emerging and established companies, including those in the renewable energy, cleantech, medical device, biotechnology, life sciences, and high tech industries.  

Erik's experience in California allows him to advise California companies and Minnesota companies looking to do business or establish a presence on the West Coast. Erik also has significant experience with general business matters, including establishment of corporations, partnerships and limited liability companies, corporate governance, stock option and equity incentive plans, and general contractual drafting and negotiation.

Education

• California Western School of Law, J.D., 2001, magna cum laude
• University of Wisconsin, B.S., Genetics, 1997

Bar Admissions

• California, 2001
• Minnesota, 2007

Practice Areas

• Renewable Energy
• Mergers & Acquisitions
• Energy
• Securities
• Corporate
• Clean Technology
• Emerging Business
• Construction

Representative Experience

• Represented AGA Medical Holdings, Inc. in its sale to St. Jude Medical, Inc.
• Represented several local wind energy development companies in connection with multinational wind project development and construction.
• Represented management in a $165,000,000 buyout of U.S. operations of a large London Stock Exchange homebuilder. 
• Represented national wind energy project development companies in multiple rounds of private and public financing.
• Represented a leading beef producer in an approximately $100,000,000 acquisition by a national beef packing company. 
• Represented a subsidiary of a large publicly-traded homebuilder in connection with the approximately $48,000,000 acquisition of all of the outstanding equity of a local developer. 
• Represented a San Diego based insurance company in a $20,000,000 stock sale to a subsidiary of a National Banking Association. 
• Represented publicly held IT company in a $9,000,000 acquisition of a defense contractor. 
• Represented a nationally recognized real estate investment group in over $50,000,000 in private equity offerings. 
• Represented a janitorial services company in an $11,000,000 acquisition by a nationally known strategic partner. 
• Represented a private internet lead generation company in an $8,000,000 acquisition by national e-commerce company. 
• Represented a high tech design company in a $6,000,000 acquisition by a global electronic manufacturing services company. 
• Represented a high tech manufacturing company in $5,000,000 of multiple rounds of private financing.

Selected Publications & Presentations

• “Internal Controls over Financial Reporting for Non-Accelerated Filers,” FredNEWS: Business, October 2008
• “Activation of the Murine Dihydrofolate Reductase Promoter by E2F1,” Journal of Biological Chemistry 274, 15883-15891, co-author, 1999
• “The Cartagena Protocol on BioSafety:  Effective Regulations or Merely an Empty Gesture?” 20 Biotechnology Law Report I, 10-15, 2001
• “Genomics to Proteomics: A Shift in Drug Discovery Focus,” San Diego Daily Transcript, September 18, 2002

Professional Activities

• California Bar Association
• Minnesota State Bar Association
• University of Wisconsin Alumni Association
• California Western Alumni Association
• National W Club

Honors & Distinctions

• 2011 Minnesota Rising Star, Minnesota Super Lawyers magazine
• Law Review and International Law Journal, Editor